Doribax 500mg powder for solution for infusion Ref.[2763]
Active ingredients:

Source: Medicines & Healthcare Products Regulatory Agency (GB) |  Revision Year: 2012 |  Publisher: Janssen-Cilag International NV Turnhoutseweg 30 B-2340 Beerse Belgium

Product name and form

Doribax 500 mg powder for solution for infusion.

Pharmaceutical Form

Powder for solution for infusion (powder for infusion).

White to slightly yellowish off-white crystalline powder.

Qualitative and quantitative composition

Each vial contains doripenem monohydrate equivalent to 500 mg doripenem.

The medicinal product does not contain any excipients.

List of Excipients

None.

Pack sizes and marketing

Clear 20 ml Type I glass vial.

The medicinal product is supplied in cartons containing 10 vials.

Marketing authorization holder

Janssen-Cilag International NV
Turnhoutseweg 30
B-2340 Beerse
Belgium

Marketing authorization dates and numbers

EU/1/08/467/001

Date of first authorisation: 25 July 2008

Drugs

Drug
Countries
DORIBAX
Estonia, Singapore, South Africa
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈